Phenotypic variability of lymphocyte populations in peripheral blood and lymph nodes from HIV-infected individuals and the impact of antiretroviral therapy

AIDS Research and Human Retroviruses

Volumn 14, Issue 5, 1998, Pages 445-451

  Landay, Alan L ^a   Bethel, James ^b   Schnittman, Steven ^c  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b WESTAT   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN; DIDANOSINE; HLA DR ANTIGEN; ZIDOVUDINE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOPHENOTYPING; LYMPHOCYTE SUBPOPULATION; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0032549551     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1998.14.445     Document Type: Article

References (47)

1. Harper ME, Marselle LM, Gallo RC, and Wong-Staal F: Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. Proc Natl Acad Sci USA 1986;83:772-776.
2. Schuurman H-J, Krone WJA, Broekhuizen R, and Goudsmit J: Expression of RNA and antigens of human immunodeficiency virus type-1 (HIV-1) in lymph nodes from HIV-1 infected individuals. Am J Pathol 1988;133:516-524.
3. Biberfeld P, Chayt KJ, Marselle LM, Biberfeld G, Gallo RC, and Harper ME: HTLV-III expression in infected lymph nodes and relevance to pathogenesis of lymphadenopathy. Am J Pathol 1986;125:436-442.
4. Baroni CD, Pezzella F, Pezzella M, Macchi B, Vitolo D, Uccini S, and Ruco LP: Expression of HIV in lymph node cells of LAS patients. Am J Pathol 1988;133:498-506.
5. Spiegel H, Herbst H, Niedobitek G, Foss H-D, and Stein H: Follicular dendritic cells are a major reservoir for human immunodeficiency virus type 1 in lymphoid tissues facilitating infection of CD4+ T-helper cells. Am J Pathol 1992;140:15-22.
6. Burke AP, Benson W, Ribas JL, Anderson D, Chu WS, Smialek J, and Virmani R: Postmortem localization of HIV-1 RNA by in situ hybridization in lymphoid tissues of intravenous drug addicts who died unexpectedly. Am J Pathol 1993;142:1701-1713.
7. Fox C, Tenner-Racz K, Racz P, Firpo A, Pizzo P, and Fauci A: Lymphoid germinal centers are reservoirs of human immunodeficiency virus type 1 RNA. J Infect Dis 1991;164:1051-1057.
8. Pantaleo G, Graziosi C, Butini L, Pizzo PA, Schnittman SM, Kotler DP, and Fauci AS: Lymphoid organs function as major reservoirs for human immunodeficiency virus. Proc Natl Acad Sci USA 1991;88:9838-9842.
9. Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH, Orenstein JM, Kotler DP, and Fauci AS: HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature (London) 1993;362:355-358.
10. Embretson J, Zupancic M, Ribas JL, Burke A, Racz P, Tenner-Racz K, and Haase AT: Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature (London) 1993;362:358-362.
11. Modlin RL, Meyer PR, Hofman FM, Mehlmauer M, Levy NB, Lukes RJ, Parker JW, Ammann AJ, Conant MA, Rea TH, and Taylor CR: T-lymphocyte subsets in lymph nodes from homosexual men. JAMA 1983;250:1302-1305.
12. Chan WC, Brynes RK, Spira TJ, Banks PM, Thurmond CC, Ewing EP Jr, and Chandler FW: Lymphocyte subsets in lymph nodes of homosexual men with generalized unexplained lymphadenopathy. Correlation with morphology and blood changes. Arch Pathol Lab Med 1985;109:133-137.
13. Garcia CF, Lifson JD, Engleman EG, Schmidt DM, Warnke RA, and Wood GS: The immunohistology of the persistent generalized lymphadenopathy syndrome (PGL). Am J Clin Pathol 1986;86: 706-715.
14. Wood GS, Burns BF, Dorfman RF, and Warnke RA: In situ quantitation of lymph node helper, suppressor, and cytotoxic T cell subsets in AIDS. Blood 1986;67:596-603.
15. Rosenberg YJ, Zack PM, White BD, Papermaster SF, Elkins WR, Eddy GA, and Lewis MG: Decline in the CD4+ lymphocyte population in the blood of SIV-infected macaques is not reflected in lymph nodes. AIDS Res Hum Retroviruses 1993;9:639-646.
16. Rosenberg YJ, Zack PM, Leon EC, White BD, Papermaster SF, Hall E, Greenhouse JJ, Eddy GA, and Lewis MG: Immunological and virological changes associated with decline in CD4/CD8 ratios in lymphoid organs of SIV-infected macaques. AIDS Res Hum Retroviruses 1994;10:863-872.
17. Meylan PR, Bürgisser P, Weyrich-Suter C, and Spertini F: Viral load and immunophenotype of cells obtained from lymph nodes by fine needle aspiration as compared with peripheral blood cells in HIV-infected patients. J Acquir Immune Defic Syndr Hum Retroviral 1969;13:39-47.
18. Holodniy M, Mole L, Schulte M, Suni M, Ruitenberg J, Lalezari J, Maino V, and Schnittman S: Relationship between lymphocyte activation and cytokine production in blood and lymph node cells. In: International Conference on AIDS, 1996;11(2):213. [Abstract Th.A.161]
19. Ramzaoui S, Jouen-Beades F, Michot F, Borsa-Lebas F, Humbert G, and Tron F: Comparison of activation marker and TCR V beta gene product expression by CD4+ and CD8+ T cells in peripheral blood and lymph nodes from HIV-infected patients. Clin Exp Immunol 1995;99:182-188.
20. Roederer M and Landay A: Flow cytometric evaluation in AIDS. In: The Handbook of Experimental Immunology (Herzenberg LA, Weir DM, and Blackwell C, eds.), 5th Ed., Vol. 4. Blackwell Science, Cambridge, Massachusetts, 1996.
21. Palmer S and Hablin AS: Increased CD11/CD18 expression on the peripheral blood leukocytes of patients with HIV disease: Relationship to disease severity. Clin Exp Immunol 1993;93:344-349.
22. Desroches CV and Rigal D: Leukocyte function-associated antigen-1 expression on peripheral blood mononuclear cell subsets in HIV-1 seropositive patients. Clin Immunol Immunopathol 1990; 56:159-168.
23. Brinchmann JE, Dobloug JH, Heger BH, Haaheim LL, Sannes M, and Egeland T: Expression of costimulatory molecule CD28 on T cells in human immunodeficiency virus type 1 infection: Functional and clinical correlations. J Infect Dis 1994;169:730-738.
24. Choremi-Papadopoulou H, Viglis V, Gargalianos P, Kordossis T, Iniotaki-Theodoraki A, and Kosmidis J: Downregulation of CD28 surface antigen on CD4+ and CD8+ T lymphocytes during HIV-1 infection. J Acquire Immune Defic Syndr 1994;7:245-253.
25. Vanham G, Kestens L, Vingerhoets J, Penne G, Colebunders R, Vandenbruaene M, Goeman J, Ceuppens JL, Sugamura K, and Gigase P: The interleukin-2 receptor subunit expression and function on peripheral blood lymphocytes from HIV-infected and control persons. Clin Immunol Immunopathol 1994;71:60-68.
26. Zola H, Koh LY, Mantzioris BX, and Rhodes D: Patients with HIV infection have a reduced proportion of lymphocytes expressing the IL-2 receptor p55 chain (TAC, CD25). Clin Immunol Immunopathol 1991;59:16-25.
27. Hofmann B, Nishanian P, Fahey JL, Esmail I, Jackson AL, Detels R, and Cumberland W: Serum increases and lymphoid cell surface losses of IL-2 receptor CD25 in HIV infection: Distinctive parameters of HIV-induced change. Clin Immunol Immunopathol 1991;61:212-224.
28. Chou CC, Gudeman V, O'Rourke S, Isacescu V, Detels R, Williams GJ, Mitsuyasu RT, and Giorgi JV: Phenotypically defined memory CD4+ cells are not selectively decreased in chronic HIV disease. J Acquire Immune Defic Syndr 1994;7:665-675.
29. Roederer M, Dubs JG, Anderson MT, Raju PA, and Herzenberg LA: CD8 naive T cell counts decrease progressively in HIV-infected adults. J Clin Invest 1995;95:2061-2066.
30. Giorgi JV, Ho HN, Hirji K, Chou CC, Hultin LE, O'Rourke S, Park L, Margolick JB, Ferbas J, Phair JP, for the The Multicenter AIDS Cohort Study Group: CD8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: Development of HLA-DR+ CD38-CD8+ cells is associated with subsequent stable CD4+ cell levels. J Infect Dis 1994;170:775-781.
31. Liu Z, Hultin LE, Cumberland WG, Hultin P, Schmid I, Matud JL, Detels R, and Giorgi JV: Elevated relative fluorescence intensity of CD38 antigen expression on CD8+ T cells is a marker of poor prognosis in HIV infection: results of 6 years of follow-up. Cytometry 1996;26:1-7.
32. Cohen OJ, Pantaleo G, Holodniy M, Fox CH, Orenstein JM, Schnittman S, Niu M, Graziosi C, Pavlakis GN, Lalezari J, Bartlett JA, Steigbigel RT, Cohn J, Novak R, McMahon D, Bilello J, and Fauci AS: Antiretroviral monotherapy in early stage human immunodeficiency virus disease has no detectable effect on virus load in peripheral blood and lymph nodes. J Infect Dis 1996; 173:849-856.
33. Cohen OJ, Pantaleo G, Holodniy M, Schnittman S, Niu M, Graziosi C, Pavlakis GN, Lalezari J, Bartlett JA, Steigbigel RT, Cohn J, Novak R, McMahon D, and Fauci AS: Decreased human immunodeficiency virus type 1 plasma viremia during antiretroviral therapy reflects downregulation of viral replication in lympoid tissue. Proc Natl Acad Sci USA 1995;92:6017-6021.
34. Haase AT, Henry K, Zupancic M, Sedgewick G, Faust RA, Melroe H, Cavert W, Gebhard K, Staskus K, Zhang ZQ, Dailey PJ, Balfour HH Jr, Erice A, and Perelson AS: Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science 1996;274: 985-989.
35. Lafeuillade A, Tamalet C, Poggi C, Pellegrino P, Tourres C, and Izopet J: Antiretroviral effect of zidovudine-didanosine combination on blood and lymph nodes. AIDS 1997;11:67-72.
36. Schapiro JM, Winters MA, Vierra M, Vanhove G, Jacobsen H, Gingeras TR, Crawford SD, Mous J, Blaschke TF, and Merigan TC: Causes of long term efficacy and/or drug failure in protease (PR) inhibitor monotherapy. In: International Conference on AIDS 1996;11(1):25. [Abstract Mo.B.414]
37. Bürgisser P, Spertini F, Weyrich-Suter C, Pagani J-L, and Meylan PRA: Monitoring responses to antiretroviral treatment in human immunodeficiency virus type 1 (HIV-1)-infected patients by serial lymph node aspiration. J Infect Dis 1997;175:1202-1205.
38. Chun TW, Carruth L, Finzi D, Shen X, DiGiuseppe JA, Taylor H, Hermankova M, Chadwick K, Margolick J, Quinn TC, Kuo YH, Brookmeyer R, Zeiger MA, Barditch-Crovo P, and Siliciano RF: Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature (London) 1997;387(6629):183-188.
39. Cavert W, Notermans DW, Staskus K, Wietgrefe SW, Zupancic M, Gebhard K, Henry K, Zhang Z-Q, Mills R, McDade H, Goudsmit J, Danner SA, and Haase AT: Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science 1997;276:960-964.
40. Landay AL, Brambilla D, Pitt J, Hillyer G, Golenbock D, Moye J, Landesman S, Kagan J, for the NAID/NICHD Women and Infants Transmission Study Group: Interlaboratory variability of CD8 subset measurements by flow cytometry and its applications to multicenter clinical trials. Clin Diag Lab Immunol 1995;2:462-468.
41. Gray CM, Morris L, Murray J, Keeton J, Shalekoff S, Lyons SF, Sonnenberg P, and Martin DJ: Identification of cell subsets expressing intracytoplasmic cytokines within HIV-1-infected lymph nodes. AIDS 1996;10:1467-1475.
42. Meyer PR, Yanagihara ET, Parker JW, and Lukes RJ: A distinctive follicular hyperplasia in the acquired immune deficiency syndrome (AIDS) and the AIDS related complex. Hematol Oncol 1984;2:319-347.
43. Baroni CD and Uccini S: The lymphadenopathy of HIV infection. Am J Clin Pathol 1993;99:397-401.
44. Graziosi C, Pantaleo G, Gantt KR, Fortin JP, Demarest JF, Cohen OJ, Sekaly RP, and Fauci AS: Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals. Science 1994;265:248-252.
45. Bass HZ, Hardy WD, Mitsuyasu RT, Want Y-X, Cumberland W, and Fahey JL: Eleven lymphoid phenotypic markers in HIV infection: selective changes induced by zidovudine treatment. J Acquir Immune Defic Syndr 1992;5:890-897.
46. Levacher M, Tallet S, Dazza MC, Dournon E, Rouveix B, and Pocidalo JJ: T activation marker evaluation in ARC patients treated with AZT. Comparison with CD4+ lymphocyte count in non-progressors and progressors towards AIDS. Clin Exp Immunol 1990; 81:177-182.
47. Liu M, Fahey JL, Aziz N, Cumberland WG, Skowron G, Merigan T, and the AIDS Clinical Trials Research Group 047: Zidovudine and dideoxycytidine differ in their effects on human immunodeficiency virus-induced pathologic activation of the immune system. J Infect Dis 1994;170:1165-1171.